Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Patients win Patent War
It's double trouble for global pharma companies in India. On April 1, a Supreme Court bench comprising Judges Aftab Alam and Ranjana Desai dismissed Swiss drug major Novartis AG's seven-year-old plea seeking
-
No to 'ever-greening'
The Pharmaceutical Research and Manufacturers of America and the United States India Business Council are miffed over the recent Novartis judgment of the Supreme Court (SC) of India. For us, however,
-
Novartis plea for patent of cancer drug: Supreme Court verdict today
The Supreme Court will pronounce on Monday its verdict in a landmark patent case involving Swiss pharma giant Novartis AG. The company has challenged the denial of patent to its blood cancer drug Glivec in India The verdict, which is crucial even for public health, is being watched closely by global pharmaceutical firms, who have been pushing for stronger patent protection in India to regulate the country's $26-billion generic drug industry.
-
Supreme Court judgement dated 01-04-2013:in Appeal Civil No. 2706-2716/2013 @ SLP(C) 20539-20549/2009 Novartis AG Vs. Union of India and ors (Patent/Cancer Drug)
Supreme Court judgement dated 01-04-2013:in Appeal Civil No. 2706-2716/2013 @ SLP(C) 20539-20549/2009 Novartis AG Vs. Union of India and ors (Patent/Cancer Drug).
-
Seed-patent case in Supreme Court
A technology called a ‘terminator’ was never going to curry much favour with the public. But even Monsanto, the agricultural biotechnology giant in St Louis, Missouri, was surprised by the furore that
-
US supreme court hears Monsanto soybean patent case
Vernon Hugh Bowman, a 75-year old Indiana farmer, says that switching to Monsanto Inc.'s "Roundup Ready" soybeans "made things so much simpler and better." Monsanto's patented beans can survive when they
-
Supreme Court Appears to Defend Patent on Soybean
A freewheeling and almost entirely one-sided argument at the Supreme Court on Tuesday indicated that the justices would not allow Monsanto’s patents for genetically altered soybeans to be threatened by
-
Lost in transition
Disputes over intellectual property rights can delay the spread of clean technologies to the developing world, but they are not wholly to blame.
-
Menacing US diplomacy
There is something that Prime Minister Manmohan Singh has in common with US diplomats—or at least the intellectual property (IP) attachés posted at various diplomatic missions: a dislike of NGOs. Both,
-
Narcissus tazetta – a case study of biopiracy
Biopiracy is a compound word consisting of ‘bio’ which is a short form for ‘biology’ and ‘piracy’. Biopirates are those individuals and industries/companies accused of one or both of the following acts: